Publications Database

Ishitobi M. et al. (2013)

Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.

Clinical Neuropharmacology

September, 36(5), pp. 151-156.

Read Abstract (New Window)

Ishitobi M. et al. (2012)

Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

April, 37(1), pp. 128-131.

Read Abstract (New Window)

Jesner O. S. , Aref-Adib M. , Coren E. (2007)

Risperidone for autism spectrum disorder.

Cochrane Database of Systematic Reviews

(1), CD005040

Read Abstract (New Window) Read Full (New Window)

Kastner T. A. (2005)

Use of risperidone in developmentally disabled children.

Pediatrics

115(5), pp. 1447-1448

Read Full (New Window)

Kent J. M. et al. (2013)

An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

23(10), pp. 676-686.

Read Abstract (New Window)

Kent J. M. et al. (2013)

Risperidone dosing in children and adolescents with autistic disorder: A double-blind, placebo-controlled study.

Journal of Autism and Developmental Disorders

43(8), pp. 1773-1783.

Read Abstract (New Window)

King B. et al. (2003)

Use of risperidone in a paediatric population: an observational study.

Journal of Paediatrics and Child Health

39(7), pp. 523-527

Read Abstract (New Window)

Kirino E. (2014)

Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children.

Clinical Medicine Insights: Pediatrics

May, 8 pp. 17-30.

Read Abstract (New Window) Read Full (New Window)

Kwon H. (2004)

Tardive dyskinesia in an autistic patient treated with risperidone.

American Journal of Psychiatry

161(4), pp. 757-758

Read Full (New Window)

Lamberti M. et al. (2016)

Head-to-head comparison of aripiprazole and risperidone in the treatment of ADHD symptoms in children with autistic spectrum disorder and ADHD: A pilot, open-label, randomized controlled study.

Pediatric Drugs

August, 18(4), pp. 319-329.

Read Abstract (New Window)

Lambrey S. et al. (2010)

Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(1), pp. 79-80.

Read Extract (New Window)

Lemmon M. E. , Gregas M. , Jeste S. S. (2011)

Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population.

Journal of Child Neurology

26(4), pp. 428-432

Read Abstract (New Window)

Levine S. et al. (2016)

Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.

Behavioral Interventions

February, 32 pp. 16-20.

Read Abstract (New Window)

Li A. et al. (2017)

Risperidone in combination with other drugs: Experimental research in individuals with autism spectrum disorder.

Experimental and Clinical Psychopharmacology

October, 25(5), pp. 434-439.

Read Abstract (New Window)

Lit L. et al. (2012)

Gene expression in blood is associated with risperidone response in children with autism spectrum disorders.

Pharmacogenomics

12(5), pp. 368-371.

Read Abstract (New Window) Read Full (New Window)

Luby J. et al. (2006)

Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 575-587

Read Abstract (New Window)

Lyra L. et al. (2017)

What do Cochrane systematic reviews say about interventions for autism spectrum disorders?

Sao Paulo Medical Journal

March-April, 135(2), pp. 192-201.

Read Abstract (New Window) Read Full (New Window)

Mahajan R. et al. (2012)

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Pediatrics

130 S125-138

Read Abstract (New Window) Read Full (New Window)

Malone R. P. , Harvey J. A. (2008)

Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 221-222

Read Extract (New Window)

Malone R. P. et al. (2002)

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

Journal of the American Academy of Child and Adolescent Psychiatry

41(2), pp. 140-147

Read Abstract (New Window)